Actinomycin D acts on NPM1 mutant-primed mitochondria by releasing mitochondrial DNA, activating cyclic GMP-AMP synthase signaling, producing reactive-oxygen species (ROS) that restores NB formation to drive TP53 activation and senescence of NPM1-mutated AML cells. This evidence concerns the gene TP53 and acute myeloid leukemia.